Melvin Sanicas

Melvin Sanicas is a seasoned professional in global medical affairs, currently serving as the Global Medical Affairs Vaccine Lead at Bavarian Nordic since September 2025. With extensive experience in vaccine strategy and public health, Melvin contributes to the Harvard Business Review Advisory Council and holds fellow positions with the Royal Society of Tropical Medicine and Hygiene and the Royal Society for Public Health. Previously, Melvin held senior roles at Exact Sciences, Clover Biopharmaceuticals, and the World Health Organization, focusing on cancer screening, infectious diseases, and digital health strategies. Melvin's educational background includes multiple advanced degrees in medicine, public health, and business from prestigious institutions, positioning Melvin as a leader in the medical and scientific community.